首頁 > 市場調查報告書 > 醫療設備

左心耳封堵器市場規模、佔有率及成長分析（依產品、手術、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898663

左心耳封堵器市場規模、佔有率及成長分析（依產品、手術、最終用戶及地區分類）－2026-2033年產業預測

Left Atrial Appendage Closure Devices Market Size, Share, and Growth Analysis, By Product (Endocardial LAA devices, Epicardial LAA devices), By Procedure (Percutaneous, Surgical), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，左心耳封堵器市場價值將達到 13.6 億美元，到 2025 年將達到 16.5 億美元，到 2033 年將達到 77.3 億美元，在預測期（2026-2033 年）內複合年成長率為 21.3%。

左心耳封堵器市場正經歷強勁成長，主要驅動力是心房顫動發生率的上升。心房顫動是一種複雜的疾病，通常需要對左心耳進行治療。導致這一成長的因素包括不健康的生活方式，例如高熱量飲食、吸煙和缺乏運動。此外，社會習慣的改變、醫療保健服務的改善以及人口老化導致心血管疾病風險增加，也進一步推動了市場需求。同時，支持介入和診斷技術改進的技術創新，也為電生理手術領域創造了巨大的成長機會。植入效果和手術安全性均顯著提高，使已開發市場和新興市場都從中受益，從而擴大了整個產業的成長潛力。

左心耳封堵器市場促進因素

心房顫動是中風和多種心臟疾病的重要危險因素，其發生率的不斷上升是左心耳封堵器（LAA封堵器）需求成長的主要促進因素。隨著人們對心房顫動相關併發症的認知不斷提高，醫療機構正積極尋求有效的解決方案來降低這些風險。左心耳封堵器正逐漸成為心房顫動患者治療中不可或缺的工具，有助於降低血栓栓塞事件的發生率。因此，確診病例的增加正在推動此類器械的市場發展，促進創新，並改善心血管健康領域的患者預後。

左心耳封堵器市場的限制因素

左心耳封堵術的複雜性，以及諸如裝置移位和術中出血等潛在併發症，嚴重阻礙了此類裝置的廣泛應用。這種複雜性可能導致醫護人員猶豫不決，尤其是那些缺乏經驗或訓練的醫護人員。因此，這種猶豫可能會阻礙左心耳封堵裝置市場的整體成長，限制患者獲得有效治療的機會，並阻礙能夠改善患者預後的介入性心臟治療策略的發展。

左心耳封堵器市場趨勢

左心耳封堵術（LAAC）器械市場正經歷著向微創手術的重大轉變，這反映了醫療保健領域改善患者預後的整體趨勢。隨著醫療機構優先考慮創傷小、恢復時間短的手術技術，LAAC器材在治療心房顫動和預防中風風險方面變得至關重要。這種微創手術的轉變不僅提高了病患的舒適度，還有助於縮短住院時間和降低整體醫療成本。因此，對創新LAAC技術的需求不斷成長，推動了市場內器械設計和手術技術的進步。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Boston Scientific Corporation（USA）
Abbott Laboratories（USA）
AtriCure, Inc.（USA）
Johnson & Johnson（USA）
Lifetech Scientific（China）
Occlutech International AB（Sweden）
Artio Medical（USA）
Cardia, Inc.（USA）
Lepu Medical Technology Co., Ltd.（China）
Conformal Medical（USA）
Nanjing YDB Technology（China）
Shanghai Push Medical Device Technology（China）
Aegis Medical Group（USA）
Acutus Medical, Inc.（USA）
FEops（Belgium）

結論與建議

簡介目錄

Product Code: SQMIG35A2586

Left Atrial Appendage Closure Devices Market size was valued at USD 1.36 Billion in 2024 and is poised to grow from USD 1.65 Billion in 2025 to USD 7.73 Billion by 2033, growing at a CAGR of 21.3% during the forecast period (2026-2033).

The market for Left Atrial Appendage Closure Devices is witnessing robust growth, largely fueled by the rising incidence of atrial fibrillation, a complex condition that often requires appendage treatment. Contributing factors to this increase include unhealthy lifestyle choices such as high-calorie diets, smoking, and physical inactivity. Furthermore, the growing demand is enhanced by changing societal habits, greater healthcare access, and an aging demographic susceptible to cardiovascular issues. Additionally, the field of electrophysiology procedures presents significant opportunities, bolstered by technological advancements that improve intervention and diagnostic techniques. Both the effectiveness of implants and the safety of procedures are witnessing substantial enhancements, benefiting not only developed countries but also emerging markets, thus broadening the industry's overall growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Left Atrial Appendage Closure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Left Atrial Appendage Closure Devices Market Segments Analysis

Global Left Atrial Appendage Closure Devices Market is segmented by Product, Procedure, End User and region. Based on Product, the market is segmented into Endocardial LAA devices and Epicardial LAA devices. Based on Procedure, the market is segmented into Percutaneous and Surgical. Based on End User, the market is segmented into Hospitals, Ambulatory surgical centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Left Atrial Appendage Closure Devices Market

The growing incidence of atrial fibrillation, which poses a substantial risk for strokes and various heart-related issues, significantly propels the demand for left atrial appendage (LAA) closure devices. As the awareness around the complications associated with atrial fibrillation expands, healthcare providers are increasingly seeking effective solutions to mitigate these risks. LAA closure devices are becoming essential tools in managing patients with atrial fibrillation, helping to reduce the likelihood of thromboembolic events. Consequently, the rising number of diagnosed cases is enhancing the market landscape for these devices, fostering innovation and improving patient outcomes in the realm of cardiovascular health.

Restraints in the Left Atrial Appendage Closure Devices Market

The intricate nature of Left Atrial Appendage (LAA) closure procedures, along with potential complications such as device migration and periprocedural bleeding, serves as a notable barrier to widespread acceptance and implementation of these devices. This complexity can deter adoption, especially among medical professionals who may not have extensive experience or training in performing such specialized procedures. As a result, this hesitation can hinder the overall growth of the LAA closure devices market, limiting patient access to potentially beneficial treatments and impeding advancements in cardiac intervention strategies that could enhance patient outcomes.

Market Trends of the Left Atrial Appendage Closure Devices Market

The Left Atrial Appendage Closure (LAAC) Devices market is experiencing a significant shift towards minimally invasive procedures, reflecting a broader trend in healthcare aimed at enhancing patient outcomes. As healthcare providers increasingly prioritize surgical techniques that minimize trauma and reduce recovery times, LAAC devices are becoming essential in managing atrial fibrillation and preventing stroke risk. This movement towards less invasive options is not only improving patient comfort but also decreasing hospital stays and overall healthcare costs. Consequently, the demand for innovative LAAC technologies is on the rise, propelling advancements in device design and procedural techniques within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Left Atrial Appendage Closure Devices Market Size by Product & CAGR (2026-2033)

Market Overview
Endocardial LAA devices
Epicardial LAA devices

Global Left Atrial Appendage Closure Devices Market Size by Procedure & CAGR (2026-2033)

Market Overview
Percutaneous
Surgical

Global Left Atrial Appendage Closure Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory surgical centers
Others

Global Left Atrial Appendage Closure Devices Market Size & CAGR (2026-2033)

North America (Product, Procedure, End User)
- US
- Canada
Europe (Product, Procedure, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Procedure, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Procedure, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Procedure, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifetech Scientific (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Occlutech International AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artio Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardia, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conformal Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanjing YDB Technology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Push Medical Device Technology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aegis Medical Group (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acutus Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FEops (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments